3,4-dihydroxyphenylacetic acid has been researched along with physostigmine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (45.45) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Felix, D; Hefti, F; Lichtensteiger, W; Lienhart, R | 1 |
Grenhoff, J; Svensson, TH | 1 |
Shillcutt, S; Soininen, H; Unni, L | 1 |
Alcorn, LM; Lee, HJ; Weiler, MH | 1 |
Ajima, A; Kato, T; Yamaguchi, T | 1 |
Laping, NJ; Ramirez, VD | 1 |
Curzon, G; Gower, A; Hutson, PH; Kennett, GA; Marcou, M; Tricklebank, MD | 1 |
Barchas, JD; Berger, PA; Davis, KL; Faull, KF; Hollister, LE | 1 |
Millington, WR; Wurtman, RJ | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetic acid and physostigmine
Article | Year |
---|---|
Characteristics of analgesias induced by brief or prolonged stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesia; Animals; Avoidance Learning; Behavior, Animal; Electroshock; Male; Physostigmine; Pyrrolidines; Rats; Rats, Inbred Strains; Restraint, Physical; Serotonin; Stress, Physiological; Time Factors | 1986 |
1 trial(s) available for 3,4-dihydroxyphenylacetic acid and physostigmine
Article | Year |
---|---|
Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Dopamine; Homovanillic Acid; Humans; Male; Middle Aged; Physostigmine; Probenecid | 1981 |
9 other study(ies) available for 3,4-dihydroxyphenylacetic acid and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Action Potentials; Animals; Caudate Nucleus; Dose-Response Relationship, Drug; Fluorescence; Homovanillic Acid; Male; Neurons; Nicotine; Physostigmine; Putamen; Rats; Receptors, Dopamine; Substantia Nigra; Time Factors | 1976 |
Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Male; Mecamylamine; Muscarine; Nicotine; Physostigmine; Rats; Rats, Sprague-Dawley; Scopolamine | 1992 |
Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Cholinesterase Inhibitors; Cholinesterases; Dichlorvos; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Norepinephrine; Physostigmine; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Tacrine; Trichlorfon | 1990 |
Effects of various experimental manipulations on neostriatal acetylcholine and dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Choline; Corpus Striatum; Dopamine; In Vitro Techniques; Kinetics; Male; Norepinephrine; Oxidopamine; Physostigmine; Potassium; Rats; Rats, Inbred F344 | 1991 |
Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Homovanillic Acid; Kinetics; Male; Physostigmine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Corpus Striatum; Dopamine; Hydroxydopamines; Male; Oxidopamine; Physostigmine; Prolactin; Rats; Substantia Nigra; Sympathectomy, Chemical; Yawning | 1988 |
Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Choline; Corpus Striatum; Drug Synergism; Haloperidol; Homovanillic Acid; Male; Phenylacetates; Physostigmine; Rats; Rats, Inbred Strains | 1982 |